在EHDS中扩展罕见疾病和罕见癌症患者摘要
Annalisa Trama1, Ana Rath2, Catherine Chronaki3
1Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Studies in health technology and informatics
|July 1, 2025
概括
欧洲卫生数据空间需要增强罕见疾病和罕见癌症的患者摘要. 本研究提出了必要的数据元素,以改善对这些罕见疾病的护理和研究.
科学领域:
- 医疗信息学 医疗信息学
- 罕见疾病研究研究 罕见疾病研究
- 在瘤学瘤学.
背景情况:
- 有超过6000种罕见疾病 (RD) 和200种罕见癌症 (RC),通常是多系统性的.
- 由于稀有性,有限的知识和理解影响了患者的护理和研究.
- 欧洲健康数据空间 (EHDS) 旨在赋予个人健康数据控制权.
研究的目的:
- 在EHDS框架内审查RD和RC患者摘要的基本数据元素.
- 建议针对RD和RC患者需求量身定制的患者摘要的数据元素扩展.
- 为了弥合罕见疾病和罕见癌症的初级和二级数据使用.
主要方法:
- 对患者总结的基本数据元素的审查.
- 对计划和非计划护理的用例分析.
- 建议对RD和RC患者摘要的数据元素扩展.
主要成果:
- 确定了DR和RC患者摘要的基本数据元素.
- 建议扩展目前的患者汇总标准.
- 解决了RD和RC患者的特殊需求,以改善数据共享.
结论:
- 增强的患者总结对于有效管理罕见疾病和罕见癌症至关重要.
- 拟议的数据元素支持初级保健和二级数据用于研究和政策.
- 在EHDS中实施可以显著改善罕见疾病和罕见癌症患者的治疗结果.
相关概念视频
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Methods of Documentation VII: EMR
921
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
921
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


